TODAY'S HEADLINES
Statin therapy is now recommended for approximately 33 million Americans who don't have cardiovascular disease, but have an estimated 10-year CV risk of 7.5% or higher. » More |
|
After manufacturers began printing new warnings on medicine bottles, a smaller percentage of emergency room visits resulted from children taking cold and cough products, according to a study in Pediatrics. » More |
ADVERTISEMENT
 The Obesity Epidemic
More than 78 million U.S. adults and 12 million children and adolescents are obese, and those numbers increase every day. Articles, video, whitepapers, and resources to help you adapt your practice to confront the growing epidemic.
|
|
The American Society of Health-System Pharmacists is backing FDA's recommendation that hydrocodone combination products be reclassified as Schedule II drugs under the Controlled Substances Act. » More |
|
Bernard Lisitza has been rewarded more than $31 million for whistleblower information provided in cases against Walgreens, CVS, Omnicare, and Johnson & Johnson, according to a report in the Chicago Tribune. » More |
Continuing Education
This month, Drug Topics offers the first of a two-part CPE series, "MTM considerations in multiple sclerosis." Earn up to 2 credits by completing this knowledge-based activity. To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to log in.
Announcement: Welcome to the new user registration process. This new process requires all pharmacists and pharmacy technicians to provide
or update their NABP e-Profile ID in order to electronically keep track of CPE credits from ACPE-accredited providers. If you have not done so, you can obtain your NABP e-Profile ID now at www.MyCPEmonitor.net. This profile will enable you to have one login
for all the NABP programs and services you will need throughout your career. |
|
|
Like
Tweet
